deltatrials
Terminated NA INTERVENTIONAL 1-arm NCT03645681

Evaluating the Safety and Effectiveness of the InnAVasc Graft for Dialysis Access in Patients With Kidney Failure

A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Updated 18 times since 2018 Last updated: Apr 28, 2025 Started: Jan 2, 2019 Primary completion: Sep 28, 2019 Completion: Jan 16, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Concerns around a high rate of thrombosis associated with kinking between the pod and the non-ringed graft.

This NA trial investigates Kidney Failure, Chronic and Renal Dialysis and is currently terminated or withdrawn. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) leads this study, which shows 18 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Sep 2018 – ~Dec 2018 · 3 months · monthly snapshot~Dec 2018 – ~Feb 2019 · 2 months · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~Oct 2019 · 7 months · monthly snapshot~Oct 2019 – ~Feb 2020 · 4 months · monthly snapshot~Feb 2020 – ~Mar 2020 · 29 days · monthly snapshot~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshot~Jan 2021 – ~Mar 2022 · 14 months · monthly snapshot~Mar 2022 – ~Sep 2022 · 6 months · monthly snapshot~Sep 2022 – ~Jul 2023 · 10 months · monthly snapshot~Jul 2023 – ~Jun 2024 · 11 months · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshot~Jan 2025 – ~Apr 2025 · 3 months · monthly snapshot~Apr 2025 – ~May 2025 · 30 days · monthly snapshot~May 2025 – ~Jun 2025 · 31 days · monthly snapshot~Jun 2025 – present · 13 months · monthly snapshot

Change History

18 versions recorded
  1. Jun 2025 — Present [monthly]

    Terminated NA

  2. May 2025 — Jun 2025 [monthly]

    Terminated NA

  3. Apr 2025 — May 2025 [monthly]

    Terminated NA

    Status: CompletedTerminated

  4. Jan 2025 — Apr 2025 [monthly]

    Completed NA

    Status: Active Not RecruitingCompleted

  5. Sep 2024 — Jan 2025 [monthly]

    Active Not Recruiting NA

Show 13 earlier versions
  1. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting NA

  2. Jun 2024 — Jul 2024 [monthly]

    Active Not Recruiting NA

  3. Jul 2023 — Jun 2024 [monthly]

    Active Not Recruiting NA

  4. Sep 2022 — Jul 2023 [monthly]

    Active Not Recruiting NA

    Status: Unknown StatusActive Not Recruiting

  5. Mar 2022 — Sep 2022 [monthly]

    Unknown Status NA

    Status: Active Not RecruitingUnknown Status

  6. Jan 2021 — Mar 2022 [monthly]

    Active Not Recruiting NA

  7. Mar 2020 — Jan 2021 [monthly]

    Active Not Recruiting NA

  8. Feb 2020 — Mar 2020 [monthly]

    Active Not Recruiting NA

  9. Oct 2019 — Feb 2020 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  10. Mar 2019 — Oct 2019 [monthly]

    Recruiting NA

  11. Feb 2019 — Mar 2019 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

  12. Dec 2018 — Feb 2019 [monthly]

    Not Yet Recruiting NA

  13. Sep 2018 — Dec 2018 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • W.L.Gore & Associates
Data source: W.L.Gore & Associates

For direct contact, visit the study record on ClinicalTrials.gov .